🇺🇸 FDA

Drug profile · INN

tasimelteon

HETLIOZ

approved N05CH
US status
approved
Patents linked
8
News articles
0

Quick answer

tasimelteon (HETLIOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN tasimelteon
Brand HETLIOZ
Route ORAL
Formulation CAPSULE
ATC code N05CH

Related patents

Search patents →

Frequently asked questions

What is tasimelteon?

tasimelteon (HETLIOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for tasimelteon?

HETLIOZ is a marketed brand name for tasimelteon. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tasimelteon?

tasimelteon has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.